Klaus Reither
Swiss Tropical and Public Health Institute(CH)University of Basel(CH)
Publications by Year
Research Areas
Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis, Pneumonia and Respiratory Infections, Pneumocystis jirovecii pneumonia detection and treatment, Diagnosis and treatment of tuberculosis
Most-Cited Works
- → High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial(2016)382 cited
- → Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis(2015)249 cited
- → Preferential infection and depletion of Mycobacterium tuberculosis –specific CD4 T cells after HIV-1 infection(2010)235 cited
- → Rapid and Accurate Detection of Mycobacterium tuberculosis in Sputum Samples by Cepheid Xpert MTB/RIF Assay—A Clinical Validation Study(2011)164 cited
- → Increased and Expedited Case Detection by Xpert MTB/RIF Assay in Childhood Tuberculosis: A Prospective Cohort Study(2012)148 cited
- → Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial